Cardinal Buying Boron LePore, Highlights Pre-Launch Market Development
Executive Summary
Cardinal Health is highlighting Boron LePore's pre-launch market development activities and relationships with smaller pharma/biotech firms as key assets in the proposed $194 mil. acquisition of the marketing services company
You may also be interested in...
Cardinal To Run Xigris Emergency Distribution Via Acquisition Of Syncor
Cardinal will be the emergency supplier of Lilly's sepsis agent Xigris following the wholesaler's acquisition of the nuclear pharmacy company Syncor
Cardinal To Run Xigris Emergency Distribution Via Acquisition Of Syncor
Cardinal will be the emergency supplier of Lilly's sepsis agent Xigris following the wholesaler's acquisition of the nuclear pharmacy company Syncor
AdvancePCS Acquisitions To Focus On Disease Management; VP Heads Effort
AdvancePCS' acquisition strategy will focus on disease management solutions that can be cross-marketed with existing products, CEO David Halbert told analysts on the PBM's year-end conference call